APO AI polypeptides, diagnostic methods and systems for quantifying APO AI, and therapeutic methods
US5814467A · kind A · utility
29Cited by
6References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 1994 |
| Grant date | Sep 29, 1998 |
| Priority date | — |
| Expiry date | Aug 19, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/812
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention describes an Apo AI polypeptide capable of immunologically mimicking an Apo AI epitope. The polypeptide is useful in diagnostic methods and systems for detecting Apo AI in vascular fluid samples, and for preparation of anti-Apo AI antibodies. In addition, the polypeptide is useful in therapeutic methods for increasing esterified cholesterol in a human patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.